| Glen Y Yoshida, MD | |
|
4440 S Washington St - Altru Professional Center, Grand Forks, ND 58201 | |
| (701) 732-7000 | |
| Not Available |
| Full Name | Glen Y Yoshida |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 42 Years |
| Location | 4440 S Washington St - Altru Professional Center, Grand Forks, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710073077 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 7434 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Altru Hospital | Grand forks, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Altru Health System | 1355251604 | 531 |
| Altru Health System | 1355251604 | 531 |
News Archive
According to today's headlines, just as President Obama signed the last piece of the health overhaul into law, the U.S. Chamber of Commerce launched efforts to shape its regulatory language. Meanwhile, analysis of particular policies included in the sweeping measure continue.
Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
In MS, the body's immune system attacks myelin, a fatty tissue that wraps and insultates nerve fibers, disrupting the transmission of signals in the central nervous system.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced revenue of $14.5 million for its seasonally impacted third quarter of 2010. Revenue from product sales in the United States was $11.6 million, reflecting growth of 8.1 percent and international revenue was $2.9 million, reflecting 19.2 percent growth on a constant currency basis or 12.7 percent on a GAAP basis.
› Verified 2 days ago
| Entity Name | Altru Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760494330 PECOS PAC ID: 1355251604 Enrollment ID: O20031110000135 |
News Archive
According to today's headlines, just as President Obama signed the last piece of the health overhaul into law, the U.S. Chamber of Commerce launched efforts to shape its regulatory language. Meanwhile, analysis of particular policies included in the sweeping measure continue.
Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
In MS, the body's immune system attacks myelin, a fatty tissue that wraps and insultates nerve fibers, disrupting the transmission of signals in the central nervous system.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced revenue of $14.5 million for its seasonally impacted third quarter of 2010. Revenue from product sales in the United States was $11.6 million, reflecting growth of 8.1 percent and international revenue was $2.9 million, reflecting 19.2 percent growth on a constant currency basis or 12.7 percent on a GAAP basis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glen Y Yoshida, MD 2401 Demers Ave, Grand Forks, ND 58201 Ph: (701) 780-1891 | Glen Y Yoshida, MD 4440 S Washington St - Altru Professional Center, Grand Forks, ND 58201 Ph: (701) 732-7000 |
News Archive
According to today's headlines, just as President Obama signed the last piece of the health overhaul into law, the U.S. Chamber of Commerce launched efforts to shape its regulatory language. Meanwhile, analysis of particular policies included in the sweeping measure continue.
Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
In MS, the body's immune system attacks myelin, a fatty tissue that wraps and insultates nerve fibers, disrupting the transmission of signals in the central nervous system.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced revenue of $14.5 million for its seasonally impacted third quarter of 2010. Revenue from product sales in the United States was $11.6 million, reflecting growth of 8.1 percent and international revenue was $2.9 million, reflecting 19.2 percent growth on a constant currency basis or 12.7 percent on a GAAP basis.
› Verified 2 days ago
Dr. Mark Strand, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4440 S Washington St, Grand Forks, ND 58201 Phone: 701-732-7000 Fax: 701-780-1889 | |
Gregory C Lapp, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4440 S Washington St - Altru Professional Center, Grand Forks, ND 58201 Phone: 701-732-7000 | |
Gwendolyn J. Beck, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1000 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 |